Cargando…
MIF Contributes to Trypanosoma brucei Associated Immunopathogenicity Development
African trypanosomiasis is a chronic debilitating disease affecting the health and economic well-being of many people in developing countries. The pathogenicity associated with this disease involves a persistent inflammatory response, whereby M1-type myeloid cells, including Ly6C(high) inflammatory...
Autores principales: | Stijlemans, Benoît, Leng, Lin, Brys, Lea, Sparkes, Amanda, Vansintjan, Liese, Caljon, Guy, Raes, Geert, Van Den Abbeele, Jan, Van Ginderachter, Jo A., Beschin, Alain, Bucala, Richard, De Baetselier, Patrick |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4177988/ https://www.ncbi.nlm.nih.gov/pubmed/25255103 http://dx.doi.org/10.1371/journal.ppat.1004414 |
Ejemplares similares
-
Iron Homeostasis and Trypanosoma brucei Associated Immunopathogenicity Development: A Battle/Quest for Iron
por: Stijlemans, Benoit, et al.
Publicado: (2015) -
MIF-Mediated Hemodilution Promotes Pathogenic Anemia in Experimental African Trypanosomosis
por: Stijlemans, Benoît, et al.
Publicado: (2016) -
Neutrophils enhance early Trypanosoma brucei infection onset
por: Caljon, Guy, et al.
Publicado: (2018) -
Immune Evasion Strategies of Trypanosoma brucei within the Mammalian Host: Progression to Pathogenicity
por: Stijlemans, Benoît, et al.
Publicado: (2016) -
Nanobodies As Tools to Understand, Diagnose, and Treat African Trypanosomiasis
por: Stijlemans, Benoit, et al.
Publicado: (2017)